Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01331915
Show Display Options
Rank Status Study
1 Unknown  Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients
Condition: Melanoma
Intervention: Biological: Theravac

Indicates status has not been verified in more than two years